சீனா சர்வதேச பரிமாற்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா சர்வதேச பரிமாற்றம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா சர்வதேச பரிமாற்றம் Today - Breaking & Trending Today

AiXin Life International, Inc. Organizes the China

CHENGDU, CHINA, May 26, 2021 (GLOBE NEWSWIRE) AiXin Life International, Inc. (OTCQX: AIXN) (hereinafter referred to as the “Company” or “AIXN”), a. ....

Yang Yiyong , Zhao Wenxiang , Yu Xiaodong , Fu Hongqiao , Sun Junmao , Lin Quanzhong , Jin Xiaotao , National Health , Healthy China Press Conference , Aixin Life International Inc , National Development , China Healthcare Nutrition Industry Development Forum , Reform Commission Institute Of Social Development , National Food , Aixin Zhonghong Biotechnology Co Ltd , National Public Nutrition Improvement Project Steering Committee , China International Exchange , Nutrition Advisory Committee , Promotion Association For , Chengdu Aixin Zhonghong Biotechnology Co Ltd , Family Planning Commission , Rural Affairs , Chinese Academy Of Social Sciences , Aixin Life International , Nutrition Industry Development Forum , China Healthcare ,

The World's First Published Expert Consensus on ARNI Treatment For Hypertension

The World s First Published Expert Consensus on ARNI Treatment For Hypertension
Chinese Expert Recommendation On The Clinical Application Of Sacubitril/Valsartan in Patients With Hypertension
Perspectives
A
The Chinese Expert Consensus Recommendations on the Clinical Application of Sacubitril/valsartan in Patients With Hypertension document was recently published in the
Chinese Journal of Hypertension (2021; 29(2): 108-114). The recommendations were jointly compiled by the hypertension branch of the China International Exchange and Promotive Association for Medical and Health Care, the cardiovascular branch of the Chinese Medical Doctor Association, and the Chinese Hypertension League. Because it is the first expert consensus on the treatment of hypertension using angiotensin receptor neprilysin inhibitor (ARNI), it is expected to serve as an important reference for developing standardized clinical application protocols for this drug. ....

Sacubitril Valsartan , Yong Huo , Promotive Association For , China National Medical Products Administration , China International Exchange , Chinese Hypertension League , Health Care , Chinese Medical Doctor Association , Chinese Expert Consensus Recommendations , Clinical Application , Patients With Hypertension , Chinese Journal , Promotive Association , Chinese Hypertension , National Medical Products Administration , Heart Failure , Acute Heart Failure , யோங் ூஓ , சீனா சர்வதேச பரிமாற்றம் , ஆரோக்கியம் பராமரிப்பு , சீன மருத்துவ மருத்துவர் சங்கம் , மருத்துவ விண்ணப்பம் , நோயாளிகள் உடன் உயர் இரத்த அழுத்தம் , சீன இதழ் , இதயம் தோல்வி , எடுப்போசை இதயம் தோல்வி ,

Biogen Inc.: Biogen Grows Presence in China with the Approval of TECFIDERA (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis

(1)
TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with urgent clinical needs
More than 500,000 individuals worldwide living with multiple sclerosis (MS) have been treated with TECFIDERA, which has a well-established safety and efficacy profile
Biogen s expansion in China now includes treatment options approved for relapsing MS and spinal muscular atrophy
CAMBRIDGE, Mass., April 15, 2021(Nasdaq: BIIB) today announced that China s National Medical Products Administration (NMPA) has approved TECFIDERA
(dimethyl fumarate) for the treatment of relapsing multiple sclerosis (MS). First introduced in 2013, TECFIDERA has demonstrated a well-established safety and efficacy profile with more than 10 years of data from clinical trials and real-world experience. ....

United Kingdom , David Caouette , Mike Hencke , Walter Gilbert , Charles Weissmann , Heinz Schaller , Kenneth Murray , Rachid Izzar , Chinese Medical Association , Chinese Society Of Neurology , Exchange Commission , Promotive Association For , China National Medical Products Administration , China International Exchange , Royal College , National Medical Products Administration , Intercontinental Region , Third Batch , New Overseas Drugs Urgently Needed , Clinical Settings , Drug Evaluation , Important Safety Informationand , Prescribing Information , Patient Informationfor , Nobel Prize , Today Biogen ,